LENSAR, Inc.
Close on Oct 19, 2026
- Market cap
- $132.41M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | Before market open | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 8, 2026 | Before market open | $13.40M | $0.00 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 31, 2026 | Before market open | – | $-0.12 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | Before market open | $14.30M | $-0.31 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | Before market open | $13.90M | $-0.15 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | Before market open | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | Before market open | $16.70M | $-1.61 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 7, 2024 | Before market open | $13.50M | $-0.13 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 4, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Feb 27, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| revenue growth | first-quarter 2025 | 27% growth | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Lensar filed with the SEC
LENSAR ® Reports Second Quarter 2026 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR ® Reports First Quarter 2026 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR ® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
Material agreement · Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
LENSAR ® Provides Update on Pending Acquisition
Regulation FD disclosure · EX-99.1 to Form 8-K
LENSAR ® Reports Third Quarter 2025 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Second Quarter 2025 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports First Quarter 2025 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
MEDIA RELEASE COMMUNIQUE AUX MEDIAS MEDIENMITTEILUNG
Material agreement · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Voting Agreement (this Agreement ), dated as of March 23, 2025, is entered into by and among Alcon Research, LLC, a Delaware limited liability company ( Parent ), and the stockholder of LENSAR, Inc., a Delaware
Material agreement · Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Third Quarter 2024 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
Agreement terminated · Results of operations · EX-99.1 to Form 8-K
LENSAR Reports First Quarter 2024 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Second Quarter 2023 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports First Quarter 2023 Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
Results of operations · EX-99 to Form 8-K
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
Results of operations · EX-99 to Form 8-K
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Announces Application for Certification of the ALLY
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K